1. Home
  2. KOPN vs CADL Comparison

KOPN vs CADL Comparison

Compare KOPN & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kopin Corporation

KOPN

Kopin Corporation

HOLD

Current Price

$3.93

Market Cap

396.8M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.21

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOPN
CADL
Founded
1984
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.8M
357.4M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
KOPN
CADL
Price
$3.93
$6.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$4.69
$19.00
AVG Volume (30 Days)
6.3M
1.7M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
103.03
58.62
EPS
0.01
N/A
Revenue
$1,530,311.00
$125,000.00
Revenue This Year
$50.07
N/A
Revenue Next Year
$33.33
N/A
P/E Ratio
$399.00
N/A
Revenue Growth
46.53
N/A
52 Week Low
$1.23
$4.34
52 Week High
$4.63
$7.66

Technical Indicators

Market Signals
Indicator
KOPN
CADL
Relative Strength Index (RSI) 78.35 57.12
Support Level $2.24 $5.42
Resistance Level $4.16 $6.41
Average True Range (ATR) 0.35 0.49
MACD 0.11 0.05
Stochastic Oscillator 66.26 51.12

Price Performance

Historical Comparison
KOPN
CADL

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: